Ebola Virus Disease

The U.S. sent Gilead Sciences Inc's (NASDAQ: GILD) remdesivir and Mapp Biopharmaceutical Inc's experimental Ebola antibody drug MBP134 to Uganda as a response to the Ebola outbreak. The medicines will help safeguard healthcare workers responding to an outbreak that has...

The World Health Organization (WHO) has published its first guideline for Ebola virus disease therapeutics, with new recommendations for using two monoclonal antibodies.  Following a systematic review and meta-analysis, WHO recommended two monoclonal antibody treatments, Ebanga (...

American pharmaceutical company Merck & Co., Inc. (NYSE: MRK) received FDA approval for its Ebola vaccine Ervebo on Thursday, according to Reuters. What Happened The FDA said had approved Merck’s Ebola vaccine, Ervebo, making it the first FDA-approved vaccine against the lethal virus...